Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-8,167
Closed -$1.45M 3038
2017
Q2
$1.41M Buy
+8,167
New +$1.33M 0.03% 867
2017
Q1
Sell
-6,287
Closed -$1.04M 2869
2016
Q4
$919K Buy
+6,287
New +$946K 0.02% 1008
2016
Q3
Sell
-1,540
Closed -$260K 3030
2016
Q2
$234K Sell
1,540
-16,467
-91% -$2.56M ﹤0.01% 2111
2016
Q1
$2.7M Buy
+18,007
New +$2.68M 0.05% 534
2015
Q4
Sell
-20,297
Closed -$3.19M 3567
2015
Q3
$2.81M Sell
20,297
-6,587
-25% -$1.04M 0.03% 863
2015
Q2
$4.13M Sell
26,884
-14,529
-35% -$2.33M 0.04% 674
2015
Q1
$6.62M Buy
41,413
+13,536
+49% +$2.13M 0.07% 404
2014
Q4
$4.44M Buy
+27,877
New +$4.34M 0.03% 870
2014
Q3
Sell
-53,145
Closed -$6.94M 4280
2014
Q2
$6.29M Sell
53,145
-42,342
-44% -$4.9M 0.03% 815
2014
Q1
$11.8M Sell
95,487
-73,065
-43% -$8.86M 0.07% 372
2013
Q4
$19.2M Buy
168,552
+21,803
+15% +$2.48M 0.1% 195
2013
Q3
$16.4M Buy
146,749
+109,967
+299% +$11.9M 0.1% 190
2013
Q2
$3.63M Buy
+36,782
New +$3.82M 0.02% 927

Other funds holding AMGN

Spot Trading's AMGN Position: Q3 2017 in Review

Spot Trading sold out of Amgen (AMGN) in Q3 2017, closing a stake of 8,167 shares — an estimated $1.45M sold.

Spot Trading first reported a position in AMGN in Q2 2013 and held it in 13 quarters. The position peaked at $19.2M in Q4 2013. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

  • Spot Trading reported no remaining Amgen position as of Q3 2017 after selling out during the quarter.
  • Spot Trading sold 8,167 Amgen shares in Q3 2017, an estimated $1.45M.
  • Spot Trading first reported a position in Amgen in Q2 2013 and held it in 13 quarters.
  • Spot Trading's Amgen position peaked at $19.2M in Q4 2013.
  • 1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.